-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on MasTec, Lowers Price Target to $320

Benzinga·10/19/2026 19:28:08
Barclays analyst Adam Seiden maintains MasTec (NYSE:MTZ) with a Overweight and lowers the price target from $340 to $320.